A Phase IIa Open Label Study to Evaluate the Safety, Tolerability and Efficacy of S-1226 Administered by Nebulization in Subjects with Cystic Fibrosis Lung Disease
Grishma Shrestha, Racheal Githumbi, Bryce Oslanski, Nadia Lachman, Daria Venkova, Ben Montgomery, Cora Pieron, John Dennis, Candice L Bjornson, Julie Jarand, Michael Parkins, Ashten Langevin, Kate Skolnik, Lori Fairservice, Clare Smith, Francis Green, Mark Montgomery
doi: https://doi.org/10.1101/2021.12.10.21266937
